KS Industry Co., Ltd. · 주식등의대량보유상황보고서(일반)
Report on large shareholdings (general)
6.1
주식회사 케이에스인더스트리
0000
20261002
Report on Large Holdings of Shares, etc.
| (General form: reports under Article 147 of the Financial Investment Services and Capital Markets Act with the purpose of influencing management control) |
| To: Financial Services Commission | Reporting obligation date: | 2026-10-02 |
| To: Korea Exchange | Report reference date: | 2026-11-16 |
| Reporting person: | (주)이메디슨 |
| Summary |
| Issuer name | (주)케이에스인더스트리 | Relationship to Issuer | Largest Shareholder |
| Report Type | New |
| Number of Shares Held and Holding Ratio | | Number of Shares Held | Holding Ratio |
| Previous Report | - | - |
| Current Report | 8,782,150 | 48.55 |
| Shares under key agreements: number and ratio | | Number of shares, etc. | Ratio |
| Previous Report | - | - |
| Current Report | - | - |
| Number of voting rights and holding ratio | | Number of Voting Rights | Holding Ratio |
| Previous Report | - | - |
| Current Report | 8,782,150 | 48.55 |
| Voting rights under key agreements: number and ratio | | Number of Voting Rights | Ratio |
| Previous Report | - | - |
| Current Report | - | - |
| Reason for Report | 제3자배정 유상증자 참여 등에 따른 지분보유 |
| ※ The reporting person confirms that holdings of shares, etc. by the reporting person and specially related parties as of the reference date are accurately stated per applicable laws and filing instructions, with no material misstatement or omission. |
Part 1 Report Overview
1. Issuer information
| Company Name | (주)케이에스인더스트리 | Company code | 101000 |
| Entity type | KOSDAQ-Listed Company | Total Issued Voting Shares (shares) | 18,090,203 |
2. Major shareholder information
a. Reporting person
(1) Reporting person overview
| Report Type | New | Joint signatories |
| Reporting person type | Domestic corporation | Nationality | Republic of Korea |
| Basis for Reporter Classification (only if reported as a statutory partnership or other entity) | - |
| Name (Entity Name) | Korean | (주)이메디슨 | Chinese characters (English) | e-medicine.Co.Ltd. |
| Address (Head Office) [Town/District Level Only] | 서울 강서구 강서로 | Date of Birth or Business Registration No., etc. | 484-86-01424 |
| Occupation (business) | 비메모리용 및 기타 전자집적회로 제조업 | Relationship to Issuer | Largest Shareholder |
| Business contact and person in charge | Affiliated company | (주)이메디슨 | Department | - |
| Position | CEO | Phone Number | 010-80*** |
| Name | Chen Yang | Fax number | 02-000* |
| Email address | **[email protected] |
(2) Reporting Person Details (for Corporations, Other Organizations, Statutory Associations, or Civil-Law Partnerships)
| Legal form | Corporation |
| Total Assets (or Total Assets Under Management) | 5,982,842,907 | Total Liabilities | 6,074,028,080 |
| Total Equity | -91,185,173 | Paid-in Capital | 530,000,000 |
| Representative (representative or managing partner) | Chen Yang |
| Decision-Making Body (Decision Maker) | General meeting of shareholders |
| Largest Shareholder (Largest Investor) | Chen Yang | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | 100 |
b. Specially related parties
(1) Specially related party overview
| No. | Name | Category | Specific Relationship to Reporter | Date of Birth or Business Registration No., etc. | Nationality | Address (Location) | Occupation (Business) | Relationship to Issuer |
| 1 | 이엘엠시스템(주) | Domestic corporation | Other | 385-88-00855 | Republic of Korea | 서울시 강남구 삼성로 | 반도체 시스템 | Shareholder |
| * Address to town/district level only |
(2) Details of specially related parties (for corporations, other entities, statutory or civil-law partnerships)
| Legal form | Corporation |
| Total Assets (or Total Assets Under Management) | - | Total Liabilities | - |
| Total Equity | 136,240,000 | Paid-in Capital | 136,240,000 |
| Representative (representative or managing partner) | 김인겸 |
| Decision-Making Body (Decision Maker) | General meeting of shareholders |
| Largest Shareholder (Largest Investor) | 김인겸 | Largest Shareholder Ownership (%) (Largest Investor Contribution Ratio) | 100 |
c. Collective investment manager
(Only if the reporting person or specially related party is a "collective investment vehicle" under Regulation Art. 3-10(2))
(1) Collective investment manager overview
| No. | Name | Business Registration No., etc. | Target collective investment vehicle | Nationality | Address (Location) | Remarks |
| - | - | - | - | - | - | - |
(2) Collective investment manager details
| Legal form | - |
| Paid-in Capital | - | Total Assets Under Management | - |
| Representative | - |
| Decision-Making Body (Decision Maker) | - |
| Largest Shareholder (Corporate Representative) | - | Largest Shareholder Stake | - |
3. Shares, etc. held and holding ratio
| Report reference date | Reporting person | Shares, etc. | Share Certificates | Total Issued Voting Shares (shares) |
| Name of Holder | Number of Specially Related Persons | Number of Shares, etc. (shares) | Ratio (%) | Number of Shares (shares) | Ratio (%) |
| Previous Report | - | - | - | - | - | - | - | - |
| This Report | 2026-11-16 | (주)이메디슨 | 1 | 8,782,150 | 48.55 | 8,782,150 | 48.55 | 18,090,203 |
| Change | 8,782,150 | 48.55 | 8,782,150 | 48.55 | 18,090,203 |
4. Purpose of holding
| Impact on management control |
| - 유상증자를 통한 최대주주 지위 확보 |
- 신규 이사 선임을 통한 경영권 확보
- 경영정상화를 위한 자본 조달 등 |
|---|
5. Reason for change
| Method of change | 유상 신주 취득 |
| Reason for change | Management participation |
| Reason for Change | - |
Part 2 Details of Large Holdings
1. Holdings by reporting person and specially related persons
A. Holdings by type of shares, etc.
| Relationship | Name | Date of Birth or Business Registration No., etc. | Details of Shares Held |
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Exchangeable bonds | Depositary receipts | Other | Total |
| Voting Shares | Shares Redeemable into Voting Shares | Shares Convertible into Voting Shares | Number of shares | Ratio (%) |
| Reporting person | (주)이메디슨 | 484-86-01424 | 8,003,685 | - | - | - | - | - | - | - | - | 8,003,685 | 44.24 |
| Specially Related Party | 이엘엠시스템(주) | 385-88-00855 | 778,465 | - | - | - | - | - | - | - | - | 778,465 | 4.30 |
| - | - | - | - | - | - | - | - | - | - | - | - | - |
| A | a1 | a2 | B | C | D | E | F | G | | |
| H |
| Total Issued Voting Shares (I) | Number of Potential Shares Held (a1+a2+B+C+D+E+F+G=H) | Holding Ratio (%) |
| Holding Ratio of Shares, etc. [A+H / I+H-(E+F+G)※] × 100 | Share Holding Ratio (A / I) × 100 |
| 18,090,203 | - | 48.55 | 48.55 |
※ Holding ratio calculated excluding from the denominator only exchangeable bonds exchangeable into shares, depositary receipts and derivative-linked securities with shares as underlying, and stock options settled in treasury shares
B. Holdings by form of holding
| Relationship | Name (Entity Name) | Date of Birth or Business Registration No., etc. | Type of holding equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) | Total |
| No. 1 | No. 2 | No. 3 | No. 4 | No. 5 | No. 6 | No. 7 | Number of shares | Ratio |
| Reporting person | (주)이메디슨 | 484-86-01424 | 8,003,685 | - | - | - | - | - | - | 8,003,685 | 44.24 |
| Specially Related Party | 이엘엠시스템(주) | 385-88-00855 | 778,465 | - | - | - | - | - | - | 778,465 | 4.30 |
| - | - | - | - | - | - | - | - | - | - | - |
| ※ Holdings equivalent to ownership (Article 142, Enforcement Decree of the Financial Investment Services and Capital Markets Act) - Item 1: owning shares, etc. for one's own account, in whatever name - Item 2: holding a right to claim delivery of shares, etc. under law, a sale, or other contract - Item 3: holding voting rights (including the right to direct voting) over the shares, etc. under law, a money trust, security, or other contract - Item 4: holding the authority to acquire or dispose of the shares, etc. under law, a money trust, security, discretionary investment, or other contract - Item 5: acquiring, through a unilateral reservation for sale of shares, etc., the right to complete the sale, and holding buyer status by exercising that right - Item 6: holding contractual rights under Article 5(1)(2) of the Act with shares, etc. as underlying assets, and holding buyer status by exercising those rights - Item 7: being granted stock options and holding buyer status by exercising them |
2. Contracts on shares held
A. Contract status
| Execution or amendment of key agreements (trust, collateral, lending, discretionary, OTC trading, joint holding, etc.) |
| None |
*Voting rights on unreported holdings may be restricted if execution/amendment of material contracts is not reported
B. Contract details
| No. | Name (Entity Name) | Relationship to Reporter | Date of Birth or Business Registration No., etc. | Type of shares, etc. | Number of shares, etc. | Counterparty | Contract type | Contract date (amendment date) | Contract period | Ratio | Remarks |
| - | - | - | - | - | - | - | - | - | - | - | - |
| Total (number of shares, etc.) | - | Total (ratio) | - | - |
C. Additional details if the main contract is a security agreement
| No. | Number of shares, etc. | Loan amount | Debtor | Interest rate | Collateral maintenance ratio | Other |
| - | - | - | - | - | - | - |
3. Holdings by proprietary and customer account (financial institutions only)
| Name | Relationship to Reporter | By account | Total |
| Own Account (shares) | Ratio (%) | Customer account (shares) | Ratio (%) | Total (shares) | Ratio (%) |
| - | - | - | - | - | - | - | - |
| Total | - | - | - | - | - | - |
Part 3 Material Changes Since Last Report Date
1. Summary of changes
a. Changes in shares, etc.
| Relationship | Name | Date of Birth or Business Registration No., etc. | Details of Changes in Shares, etc. |
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Exchangeable bonds | Depositary receipts | Other | Total |
| Voting Shares | Shares Redeemable into Voting Shares | Shares Convertible into Voting Shares | Number of shares | Ratio (%) |
| Reporting person | (주)이메디슨 | 484-86-01424 | 8,003,685 | - | - | - | - | - | - | - | - | 8,003,685 | 44.24 |
| Specially Related Party | - | - | - | - | - | - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - | - | - | - | - | - |
2. Change details
a. Detailed changes in shares, etc.
| Name (Entity Name) | Date of Birth or Business Registration No., etc. | Change Date* | Acquisition/disposal method | Type of shares, etc. | Change details | Acquisition/disposal unit price** | Remarks |
| Before Change | Change | After Change |
| (주)이메디슨 | 484-86-01424 | 2026-10-02 | 유상신주취득(+) | Voting Shares | - | 4,885,993 | 4,885,993 | 1,228 | - | - |
| (주)이메디슨 | 484-86-01424 | 2026-10-29 | 유상신주취득(+) | Voting Shares | 4,885,993 | 3,117,692 | 8,003,685 | 1,283 | - | - |
* For trades on the securities market, the contract date
** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities
3. Source of acquisition funds
(1) Overview of acquisition funds
| Name | Date of birth or business registration no., etc. | Own funds (H) | Borrowings (I) | Other (J) | Total (H+I+J) |
| (주)이메디슨 | 484-86-01424 | 10,000,000,000 | - | - | 10,000,000,000 |
(2) Origin and source of acquisition funds
ㅇ If own funds
| Name | Date of birth or business registration no., etc. | Source and Formation of Acquisition Funds |
| (주)이메디슨 | 484-86-01424 | 기관 및 개인투자자 등 모집 |